Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Cipla Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500087
ISIN Demat	INE059A01026
Book Value	419.19

NSE Code	CIPLA
Dividend Yield %	1.20
Market Cap	1078268.64

P/E	23.36
EPS	57.14
Face Value	2


	BSE		NSE

04-May-2026 16:01

Last Price	1334.85
Net Change	24.95
% Change	1.9%
Prev.Close	1309.90
Open	1315.60
High	1337.00
Low	1311.30
Volume	51309

Last Price	1335.00
Net Change	25.4
% Change	1.94%
Prev.Close	1309.60
Open	1320.00
High	1337.40
Low	1313.60
Volume	1088765

Value	68489818.65
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1337.00
52-Week High	1672.20
52-Week Low	1165.55

Value	1453501275
Best Buy	0.00
Best Sell	1335.00
Best Quantity	0
Sell Quantity	305
Today's Range	1337.40
52-Week High	1673.00
52-Week Low	1165.70

Open Price	1319.80
High Price	1341.00
Low Price	1319.00
Last Price	1338.00
Prev Close	1315.20
Change	22.80
% Change	1.73 %

Average Price	1332.74
Underlying Value	1335.00
Number of contracts traded	3206
Turnover in Rs. Lakhs	16023
Open Interest	13629000.00
Change in O I	-23250.00
% Change in O I	-0.17 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	305
Price	1335.00

Best Bid

Best Offer

Quantity	750
Price	1336.1

Quantity	750
Price	1338

Holding Details

Latest Corporate Events

Bonus

3 : 2

24-Apr-06

Book Closure

11-Aug-21

25-Aug-21

Dividend

150 %

27-Jun-25

Company News

23-04-2026

Cipla’s arm gets USFDA’s ...

23-04-2026

Cipla informs about discl...

23-04-2026

Cipla shines as its arm g...

18-04-2026

USFDA concludes inspectio...

20-03-2026

Cipla gets nod to invest ...

20-03-2026

Cipla surges on getting n...

09-03-2026

Cipla’s arm recalling ove...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.